ATE357535T1 - Genetische veränderungen im zusammenhang mit krebs - Google Patents

Genetische veränderungen im zusammenhang mit krebs

Info

Publication number
ATE357535T1
ATE357535T1 AT98902801T AT98902801T ATE357535T1 AT E357535 T1 ATE357535 T1 AT E357535T1 AT 98902801 T AT98902801 T AT 98902801T AT 98902801 T AT98902801 T AT 98902801T AT E357535 T1 ATE357535 T1 AT E357535T1
Authority
AT
Austria
Prior art keywords
cancer
changes associated
genetic changes
probes
nucleic acid
Prior art date
Application number
AT98902801T
Other languages
English (en)
Inventor
Laleh Shayesteh
Joe W Gray
Gordon Mills
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/783,729 external-priority patent/US6277563B1/en
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE357535T1 publication Critical patent/ATE357535T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98902801T 1997-01-16 1998-01-15 Genetische veränderungen im zusammenhang mit krebs ATE357535T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/783,729 US6277563B1 (en) 1997-01-16 1997-01-16 Genetic alterations associated with cancer
US08/837,046 US6110673A (en) 1997-01-16 1997-04-05 Genetic alterations associated with cancer
US08/905,508 US7670767B1 (en) 1997-01-16 1997-08-04 Genetic alterations associated with cancer

Publications (1)

Publication Number Publication Date
ATE357535T1 true ATE357535T1 (de) 2007-04-15

Family

ID=27419801

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98902801T ATE357535T1 (de) 1997-01-16 1998-01-15 Genetische veränderungen im zusammenhang mit krebs

Country Status (8)

Country Link
US (2) US7670767B1 (de)
EP (1) EP1038025B1 (de)
JP (1) JP2002513282A (de)
AT (1) ATE357535T1 (de)
AU (1) AU745910B2 (de)
CA (1) CA2277850C (de)
DE (1) DE69837397T2 (de)
WO (1) WO1998031324A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465177B1 (en) * 1998-10-26 2002-10-15 John Wayne Cancer Institute Detection of loss of heterozygosity in tumor and serum of melanoma patients
JP2006523456A (ja) * 2003-04-15 2006-10-19 アバロン ファーマシューティカルズ，インコーポレイテッド 分子細胞遺伝学的方法を用いる癌連鎖遺伝子および治療標的の確認
EP2497836B1 (de) * 2004-03-02 2015-01-14 The Johns Hopkins University Mutationen des PIK3CA-Gens in menschlichen Krebsen
EP2376655B1 (de) * 2008-11-14 2019-10-09 The Children's Hospital Of Philadelphia Genetische varianten der menschlichen kognition und verfahren zu ihrer verwendung als diagnostische und therapeutische ziele
KR20120031734A (ko) * 2010-09-27 2012-04-04 삼성전자주식회사 급성 골수성 백혈병 환자의 시타라빈 민감성을 예측하기 위한 키트 및 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
GB9208135D0 (en) 1992-04-13 1992-05-27 Ludwig Inst Cancer Res Polypeptides having kinase activity,their preparation and use
US5378725A (en) 1993-07-19 1995-01-03 The Arizona Board Of Regents Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
US6632789B1 (en) * 1994-04-29 2003-10-14 The United States Of America As Represented By The Secretary Of The Navy Methods for modulating T cell responses by manipulating intracellular signal transduction
US5830645A (en) * 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5759782A (en) 1995-06-07 1998-06-02 The United States Of America Cellular apoptosis susceptibility protein (CSP) and antisense CSP

Also Published As

Publication number Publication date
US7670767B1 (en) 2010-03-02
WO1998031324A2 (en) 1998-07-23
CA2277850A1 (en) 1998-07-23
DE69837397D1 (de) 2007-05-03
JP2002513282A (ja) 2002-05-08
DE69837397T2 (de) 2007-11-29
AU745910B2 (en) 2002-04-11
US20100204125A1 (en) 2010-08-12
CA2277850C (en) 2011-07-12
EP1038025A4 (de) 2004-08-18
EP1038025A1 (de) 2000-09-27
AU5960798A (en) 1998-08-07
EP1038025B1 (de) 2007-03-21

Similar Documents

Publication Publication Date Title
ATE403743T1 (de) Genetische veränderungen, die mit lungencarzinomen korrelieren
DE69638183D1 (de) Verwendung von nukleinsäureliganden in der durchflusszytometrie
HK1054980A1 (zh) 利用肝臟干細胞進行毒性分型
AU6152301A (en) Detection of nucleic acid hybridization by fluorescence polarization
DE69434663D1 (de) Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt
GB9401833D0 (en) Method for discovering ligands
EP1434877A4 (de) Chromogene in-situ-hybridisierungsverfahren, kits und zusammensetzungen
WO2003050243A3 (en) Novel genes encoding colon cancer antigens
ATE336591T1 (de) Nachweisverfahren für kurze sequenzvarianten
EP0892048A3 (de) XAF Gene und Polypeptide und deren Verwendung zur Modulation der Apoptose
WO2001036685A3 (en) Differential gene expression in cancer
AU2154801A (en) Method for linking molecular substances
DE60109430D1 (de) An entzündlichen darmerkrankungen beteiligte gene und deren verwendung
ZA200005409B (en) New nucleotide sequences which code for the eno gene.
DE69837397D1 (de) Genetische veränderungen im zusammenhang mit krebs
WO2000050595A3 (en) Nucleic acid molecules associated with melanoma and thyroid tumors
WO2003008578A3 (en) Reagents and methods for identifying gene targets for treating cancer
DK0877758T3 (da) Oprenset SR-p70-protein
WO2002031198A3 (en) Cancer-linked genes as targets for chemotherapy
AU3775099A (en) Methods, kits and compositions for detecting and quantitating target sequences
DE59814032D1 (de) Nucleinsäuremolekül, kit und verwendung
WO2005035724A3 (en) Cancer-linked genes as targets for chemotherapy
WO2003091415A3 (en) Fluorobodies and chromobodies: binding ligands with intrinsic fluorescence and color
DE69930294D1 (de) Minimale promotoren und ihre verwendung
DE69939623D1 (de) Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties